HEPATITIS C (HCV)

Clinical trials for HEPATITIS C (HCV) explained in plain language.

Never miss a new study

Get alerted when new HEPATITIS C (HCV) trials appear

Sign up with your email to follow new studies for HEPATITIS C (HCV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 4 Not yet finished but already full! 1 Completed 1

New drug naderin may help patients fight infections during cancer and TB therapy

Disease control Completed

This study tested whether adding Naderin (sodium nucleinate) to standard treatment could reduce complications in 75 patients with cancer, tuberculosis, or hepatitis C. The main group received Naderin plus standard therapy, while the control group received standard therapy alone. …

Matched conditions: HEPATITIS C (HCV)

Phase: PHASE2, PHASE3 • Sponsor: MIPO Clinic • Aim: Disease control

Last updated Jul 01, 2026 23:00 UTC

HEPATITIS C (HCV)

Get alerted when new HEPATITIS C (HCV) trials appear

New drug naderin may help patients fight infections during cancer and TB therapy